Volume: 39 Issue: 03

1. Study on the value of serum galactose-deficient IgA1 in the diagnosis of IgA nephropathy Page:270—273
2. Change of ultrasonographic signs during urate lowering therapy in patients with gout Page:274—277
3. Comparative study on etiology and complications of liver cirrhosis in a 5-year period Page:278—281
4. Clinical dilemmas in non-alcoholic fatty liver disease Page:207—209
5. Clinical characteristics of non-alcoholic fatty liver disease related hepatocellular carcinoma Page:210—213
6. Drug therapy for non-alcoholic fatty liver disease Page:214—217
7. Diagnosis and treatment of patients with lean non-alcoholic fatty liver diseases Page:218—221
8. Exercise prescription for non-alcoholic fatty liver disease Page:222—226
9. Dietary modification in patients with nonalcoholic fatty liver disease Page:227—230
10. Influence of type 2 diabetes treatment on patients with non-alcoholic fatty liver disease Page:231—234
11. Interpretation of Chinese and foreign guidelines for the diagnosis and management of nonalcoholic fatty liver disease Page:235—238
12. Clinical application of linked color imaging in gastrointestinal endoscopy Page:239—244
13. Damage of dual antiplatelet drug to gastrointestinal mucosa and endoscopic diagnosis and treatment Page:245—248
14. Diagnostic accuracy of RPR, FIB-4, APRI and AAR in liver fibrosis patients with chronic hepatitis B Page:249—253
15. Clinical control study of water colonoscopy and gas colonoscopy Page:254—256
16. Study on the expression of antiphospholipid antibody subtypes in primary glomerulopathy Page:257—259
17. The role of probiotic on protein energy wasting and micro-inflammation in peritoneal dialysis patients Page:260—264
18. Changes of biochemical indicators in maintenance hemodialysis patients before death Page:265—269